TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MedAdvisor Limited ( (AU:MDR) ) has provided an announcement.
MedAdvisor Limited has announced the appointment of Sean Slattery as a new director, effective August 29, 2025. This development is part of the company’s strategic efforts to strengthen its leadership team, although the newly appointed director currently holds no relevant interests in the company’s securities. This appointment is expected to enhance MedAdvisor’s governance and potentially impact its strategic direction in the healthcare technology sector.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital medication management solutions. The company focuses on improving patient health outcomes through its innovative technology platform, which helps users manage their prescriptions and medication schedules more effectively.
Average Trading Volume: 974,172
Technical Sentiment Signal: Sell
Current Market Cap: A$35.01M
See more insights into MDR stock on TipRanks’ Stock Analysis page.